Atrial fibrillation as a clinical characteristic of arrhythmogenic right ventricular cardiomyopathy: Experience from the Nordic ARVC Registry

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Maria A Baturova, Lund University, Saint Petersburg State University
  • ,
  • Kristina H Haugaa, University of Oslo, Oslo University Hospital
  • ,
  • Henrik K Jensen
  • Anneli Svensson, Linköping University
  • ,
  • Thomas Gilljam, Sahlgrenska University Hospital
  • ,
  • Henning Bundgaard, Københavns Universitet, Rigshospitalet
  • ,
  • Trine Madsen, Aalborg Universitet
  • ,
  • Jim Hansen, Københavns Universitet
  • ,
  • Monica Chivulescu, Oslo University Hospital, University of Oslo
  • ,
  • Morten Krogh Christiansen
  • Jonas Carlson, Lund University
  • ,
  • Thor Edvardsen, Oslo University Hospital, University of Oslo
  • ,
  • Jesper H Svendsen, Rigshospitalet, Københavns Universitet
  • ,
  • Pyotr G Platonov, Lund University
BACKGROUND: Recent studies in arrhythmogenic right ventricular cardiomyopathy (ARVC) patients have drawn attention to atrial fibrillation (AF) as an arrhythmic manifestation of ARVC and as an indicator of atrial involvement in the disease progression. We aimed to assess the prevalence of AF in the Scandinavian cohort of ARVC patients and to evaluate its association with disease clinical manifestations. METHODS: Study sample comprised of 293 definite ARVC patients by 2010 Task Force criteria (TFC2010) and 141 genotype-positive family members (total n = 434, 43% females, median age at ARVC diagnosis 41 years [interquartile range (IQR) 28-52 years]). ARVC diagnostic score was calculated as the sum of major (2 points) and minor (1 point) criteria in all categories of the TFC2010. RESULTS: AF was diagnosed in 42 patients (10%): in 41 patients with definite ARVC diagnosis (14%) vs in one genotype-positive family member (1%), p < 0.001. The median age at AF onset was 51 (IQR 38-58) years. The prevalence of AF was related to the ARVC diagnostic score: it significantly increased starting with the diagnostic score 4 (2% in those with score 3 vs 13% in those with score 4, p = 0.023) and increased further with increased diagnostic score (Somer's d value is 0.074, p < 0.001). CONCLUSION: AF is seen in 14% of definite ARVC patients and is related to the severity of disease phenotype thus suggesting AF being an arrhythmic manifestation of this cardiomyopathy indicating atrial myocardial involvement in the disease progression.
OriginalsprogEngelsk
TidsskriftInternational Journal of Cardiology
Vol/bind298
Sider (fra-til)39-43
Antal sider5
ISSN0167-5273
DOI
StatusUdgivet - jan. 2020

Bibliografisk note

Copyright © 2019 Elsevier B.V. All rights reserved.

Se relationer på Aarhus Universitet Citationsformater

ID: 162169689